Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab-Reference-Cited by-同舟云学术

Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab

Published:2020-06-18 Issue:6 Volume:15 Page:e0233957
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bhatia Sravya M.,Streilein Robert D.,Hall Russell P.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases;JR Stanley;The Journal of clinical investigation,1989

2. Immunopathology and molecular diagnosis of autoimmune bullous diseases;S Mihai;Journal of cellular and molecular medicine,2007

3. Adhesion molecules. I: Keratinocyte-keratinocyte interactions; cadherins and pemphigus;M. Amagai;The Journal of investigative dermatology,1995

4. Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients;RW Eyre;The Journal of experimental medicine,1987

5. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion;M Amagai;Cell,1991

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmunity to neuronal nicotinic acetylcholine receptors;Pharmacological Research;2023-06

2. The Role of Non-Neuronal Acetylcholine in the Autoimmune Blistering Disease Pemphigus Vulgaris;Biology;2023-02-23

3. Effectiveness of topical pilocarpine in refractory oral lesions of pemphigus vulgaris: Results from an open‐label, prospective, pilot study;Dermatologic Therapy;2022-03-25

4. Chronic exposure to the anti-M3 muscarinic acetylcholine receptor autoantibody in pemphigus vulgaris contributes to disease pathophysiology;Journal of Biological Chemistry;2022-03

5. Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris;Journal of Investigative Dermatology;2021-10